Artiva Biotherapeutics (ARTV) Enterprise Value (2023 - 2026)
Artiva Biotherapeutics (ARTV) reported Enterprise Value of -$86.8 million for Q1 2026, up 47.71% year-over-year from -$58.8 million in Q1 2025, and up 19.65% quarter-over-quarter from -$108.0 million in Q4 2025.
Artiva Biotherapeutics (ARTV) Enterprise Value (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 4 years of Enterprise Value data on file, last reported at -$86.8 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$86.8 million, up 47.71% year-over-year; the trailing twelve-month figure through Mar 2026 was -$86.8 million (up 47.71% YoY), and the FY2025 annual result was -$108.0 million, up 41.75% from the prior year.
- Enterprise Value advanced to -$86.8 million in Q1 2026 per ARTV's latest filing, from -$108.0 million in the prior quarter.
- Over five years, Enterprise Value peaked at $50.2 million in Q2 2024 and troughed at -$185.4 million in Q4 2024.
- A 4-year average of -$86.1 million and a median of -$97.4 million in 2025 frame the typical range for Enterprise Value.
- On a YoY basis, Enterprise Value climbed as much as 193.53% in 2024 and fell as far as 534.51% in 2024.
- A 4-year view of Enterprise Value shows it stood at $42.7 million in 2023, then sank by 534.51% to -$185.4 million in 2024, then soared by 41.75% to -$108.0 million in 2025, then climbed by 19.65% to -$86.8 million in 2026.
- Business Quant data shows ARTV's Enterprise Value at -$86.8 million in Q1 2026, -$108.0 million in Q4 2025, and -$123.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Artiva Biotherapeutics | 241.85 Mn | 241.85 Mn | - | -86.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -86.78 Mn |
| Dec 31, 2025 | -108.01 Mn |
| Sep 30, 2025 | -122.97 Mn |
| Jun 30, 2025 | -142.37 Mn |
| Mar 31, 2025 | -165.96 Mn |
| Dec 31, 2024 | -185.43 Mn |
| Sep 30, 2024 | -146.63 Mn |
| Jun 30, 2024 | 50.22 Mn |
| Mar 31, 2024 | -48.20 Mn |
| Dec 31, 2023 | 42.68 Mn |
| Sep 30, 2023 | -65.89 Mn |
| Jun 30, 2023 | -53.70 Mn |